Showing 49 to 60 of 152 results
Trump Budget Cuts Threaten Biomedical Research and Global Health
President Trump's proposed budget includes significant cuts to the NIH (40%), CDC (54%), and global health initiatives (over 60%), potentially hindering disease research and increasing global mortality and disability.
Trump Budget Cuts Threaten Biomedical Research and Global Health
President Trump's proposed budget includes significant cuts to the NIH (40%), CDC (54%), and global health initiatives (over 60%), potentially hindering disease research and increasing global mortality and disability.
Progress
52% Bias Score
Trump Executive Order Seeks to Lower Prescription Drug Prices
President Trump issued an executive order on May 12, 2025, aiming to lower U.S. prescription drug prices by increasing prices paid by foreign countries, facing legal and practical challenges while seeking to balance consumer benefits with pharmaceutical innovation.
Trump Executive Order Seeks to Lower Prescription Drug Prices
President Trump issued an executive order on May 12, 2025, aiming to lower U.S. prescription drug prices by increasing prices paid by foreign countries, facing legal and practical challenges while seeking to balance consumer benefits with pharmaceutical innovation.
Progress
56% Bias Score
Novo Nordisk CEO Ousted Amidst Market Challenges and Share Price Drop
Novo Nordisk abruptly ousted its CEO, Lars Fruergaard Jørgensen, due to market challenges and a significant share price decline, despite a recent increase in sales, raising concerns about the company's future in the weight-loss drug market.
Novo Nordisk CEO Ousted Amidst Market Challenges and Share Price Drop
Novo Nordisk abruptly ousted its CEO, Lars Fruergaard Jørgensen, due to market challenges and a significant share price decline, despite a recent increase in sales, raising concerns about the company's future in the weight-loss drug market.
Progress
40% Bias Score
AbbVie Stock Surges 10% on Emrelis Approval and Immunology Growth
AbbVie's stock price surged 10% in six months due to FDA approval of Emrelis for lung cancer and exceptional growth (Skyrizi +71%, Rinvoq +57%) in its immunology portfolio during Q1 2025, despite high valuation and concerns about drug price controls.
AbbVie Stock Surges 10% on Emrelis Approval and Immunology Growth
AbbVie's stock price surged 10% in six months due to FDA approval of Emrelis for lung cancer and exceptional growth (Skyrizi +71%, Rinvoq +57%) in its immunology portfolio during Q1 2025, despite high valuation and concerns about drug price controls.
Progress
40% Bias Score
Trump's Misplaced Blame for High U.S. Drug Prices
President Trump wrongly blamed high U.S. prescription drug prices on foreign nations; a RAND report showed U.S. prices were 2.78 times higher than in 33 other countries in 2022 due to the fragmented U.S. drug pricing system, prompting an executive order to tie U.S. prices to lower prices abroad.
Trump's Misplaced Blame for High U.S. Drug Prices
President Trump wrongly blamed high U.S. prescription drug prices on foreign nations; a RAND report showed U.S. prices were 2.78 times higher than in 33 other countries in 2022 due to the fragmented U.S. drug pricing system, prompting an executive order to tie U.S. prices to lower prices abroad.
Progress
40% Bias Score
Trump's Executive Order Seeks to Lower U.S. Drug Prices Amidst Global Pricing Imbalance
Donald Trump issued an executive order on Monday aiming to lower U.S. drug prices by 30-80%, following a Sunday Truth Social post; however, the plan faces legal and practical challenges, given the high profit margins and political influence of the pharmaceutical industry and the complex global prici...
Trump's Executive Order Seeks to Lower U.S. Drug Prices Amidst Global Pricing Imbalance
Donald Trump issued an executive order on Monday aiming to lower U.S. drug prices by 30-80%, following a Sunday Truth Social post; however, the plan faces legal and practical challenges, given the high profit margins and political influence of the pharmaceutical industry and the complex global prici...
Progress
48% Bias Score
Trump's Drug Pricing Order Faces Implementation Hurdles
President Trump's executive order mandates that the US pay the lowest price for drugs among peer nations, but implementation faces significant challenges due to logistical complexities, legal uncertainties, and past failures of similar initiatives.
Trump's Drug Pricing Order Faces Implementation Hurdles
President Trump's executive order mandates that the US pay the lowest price for drugs among peer nations, but implementation faces significant challenges due to logistical complexities, legal uncertainties, and past failures of similar initiatives.
Progress
40% Bias Score
German Chemical Industry Recovers in Q1 2023 Amidst Trade Concerns
Germany's chemical and pharmaceutical industry experienced a 4.4% rise in turnover to €54.8 billion in Q1 2023, recovering from previous declines, but concerns remain about US tariffs and Chinese competition; production is expected to stagnate in 2023.
German Chemical Industry Recovers in Q1 2023 Amidst Trade Concerns
Germany's chemical and pharmaceutical industry experienced a 4.4% rise in turnover to €54.8 billion in Q1 2023, recovering from previous declines, but concerns remain about US tariffs and Chinese competition; production is expected to stagnate in 2023.
Progress
40% Bias Score
Novo Nordisk CEO Steps Down Amidst Market Challenges and Share Price Plunge
Novo Nordisk CEO Lars Fruergaard Jorgensen resigned Friday due to a 50%+ share price decline since mid-2024, driven by cheaper competitor drugs and a recent head-to-head study showing a competitor's superior efficacy.
Novo Nordisk CEO Steps Down Amidst Market Challenges and Share Price Plunge
Novo Nordisk CEO Lars Fruergaard Jorgensen resigned Friday due to a 50%+ share price decline since mid-2024, driven by cheaper competitor drugs and a recent head-to-head study showing a competitor's superior efficacy.
Progress
44% Bias Score
Novo Nordisk CEO Steps Down Amidst Market Challenges and Competition
Novo Nordisk CEO Lars Fruergaard Jorgensen resigned Friday due to market challenges and declining share prices after Eli Lilly's Zepbound surpassed Wegovy in US prescriptions since mid-March; former CEO Lars Rebien Sorensen will join the board as an observer.
Novo Nordisk CEO Steps Down Amidst Market Challenges and Competition
Novo Nordisk CEO Lars Fruergaard Jorgensen resigned Friday due to market challenges and declining share prices after Eli Lilly's Zepbound surpassed Wegovy in US prescriptions since mid-March; former CEO Lars Rebien Sorensen will join the board as an observer.
Progress
40% Bias Score
Trump Decrees US Drug Price Cuts, Proposes Medicaid Cuts
US President Donald Trump issued a decree on Monday mandating that pharmaceutical companies lower drug prices in the US to match the lowest prices in other countries within 30 days, potentially resulting in 59 percent cost reductions, while simultaneously proposing significant Medicaid cuts that cou...
Trump Decrees US Drug Price Cuts, Proposes Medicaid Cuts
US President Donald Trump issued a decree on Monday mandating that pharmaceutical companies lower drug prices in the US to match the lowest prices in other countries within 30 days, potentially resulting in 59 percent cost reductions, while simultaneously proposing significant Medicaid cuts that cou...
Progress
48% Bias Score
Trump Executive Order Aims to Slash Prescription Drug Prices
President Trump signed an executive order to lower prescription drug prices in the U.S. by referencing prices in other developed countries, potentially reducing costs by 50-90% for some drugs; however, full implementation requires further rule-making by government agencies.
Trump Executive Order Aims to Slash Prescription Drug Prices
President Trump signed an executive order to lower prescription drug prices in the U.S. by referencing prices in other developed countries, potentially reducing costs by 50-90% for some drugs; however, full implementation requires further rule-making by government agencies.
Progress
40% Bias Score
Showing 49 to 60 of 152 results